Emerging research is reshaping our understanding of coenzyme Q10’s critical role in cardiovascular health. Rather than functioning primarily as an antioxidant, CoQ10 acts as the essential electron shuttle within mitochondrial membranes, directly enabling the cellular energy production that keeps the heart beating efficiently.
This distinction carries significant clinical implications, particularly regarding statin therapy. Statins reduce CoQ10 levels by inhibiting HMG-CoA reductase, the same enzyme responsible for both cholesterol and CoQ10 synthesis. By blocking this shared metabolic pathway, statins inadvertently compromise the heart’s capacity for aerobic energy production.
Understanding CoQ10’s primary mechanistic role in cardiac ATP synthesis offers new perspectives on cardiovascular health management and the potential trade-offs of cholesterol-lowering interventions.
Was this article helpful?
100% of readers found this helpful (1 votes)
